Geron reported $834.2M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Amgen USD 150.13B 17.37B Jun/2025
Bio Techne USD 8.07B 1.2B Jun/2025
Cassava Sciences USD 99M 12M Sep/2025
Cytokinetics USD 3.95B 846M Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 898M 115M Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
MacroGenics USD 111M 34M Sep/2025
Novartis CHF 256.18B 64.49B Jun/2025